Pro-ADM for Prognosis of Trauma-Related Complications in Polytrauma
US-2026056215-A1 · Feb 26, 2026 · US
This page is not indexed by search engines while we improve data quality.
Wilson Darius patents
Wilson Darius is listed as an inventor on 22 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Wilson Darius |
| Total patents | 22 |
| First publication | Aug 20, 2020 |
| Latest publication | Feb 26, 2026 |
Notable patents
Publications ranked by popularity score, then publication date.
Pro-ADM for prognosis of trauma-related complications in polytrauma patients
US-12560620-B2 · Feb 24, 2026 · US
Method for guidance of fluid therapy based on proadrenomedullin
US-12517138-B2 · Jan 6, 2026 · US
Method for preparing a sample
US-12405279-B2 · Sep 2, 2025 · US
Sample including pro-adm as a therapy monitoring marker for critcally ill patients
US-2025189539-A1 · Jun 12, 2025 · US
Workflow for risk assessment and patient management using procalcitonin and midregional-proadrenomedullin
US-12265092-B2 · Apr 1, 2025 · US
Antibiotic therapy guidance based on procalcitonin in patients with comorbidities
US-2024393352-A1 · Nov 28, 2024 · US
Antibiotic therapy guidance based on procalcitonin in patients with comorbidities
US-12153057-B2 · Nov 26, 2024 · US
Method for discharging a patient from an intensive care unit
US-12000845-B2 · Jun 4, 2024 · US
Method for discharging a patient from an intensive care unit
US-2022229076-A1 · Jul 21, 2022 · US
Recent patents
Latest publications not already listed above.
Method for preparing a sample
US-2022221474-A1 · Jul 14, 2022 · US
Method for the diagnosis of macce in patients who underwent gastrointestinal surgery
US-2022196678-A1 · Jun 23, 2022 · US
Proadrenomedullin as a marker for abnormal platelet levels
US-11327082-B2 · May 10, 2022 · US
Pro-ADM for Prognosis of Trauma-Related Complications in Polytrauma Patients
US-2021405070-A1 · Dec 30, 2021 · US
Pro-adm for prognosing the risk of a medical condition requiring hospitalization in patients with symptoms of infectious disease
US-2021293830-A1 · Sep 23, 2021 · US
Workflow for risk assessment and patient management using procalcitonin and midregional-proadrenomedullin
US-2021109117-A1 · Apr 15, 2021 · US
Antibiotic therapy guidance based on pro-adm
US-2021109118-A1 · Apr 15, 2021 · US
Antibiotic therapy guidance based on procalcitonin in patients with comorbidities
US-2020319212-A1 · Oct 8, 2020 · US
Pro-adm as a therapy monitoring marker for critcally ill patients
US-2020300864-A1 · Sep 24, 2020 · US
Proadrenomedullin as a marker for abnormal platelet levels
US-2020271675-A1 · Aug 27, 2020 · US
Method for guidance of fluid therapy based on proadrenomedullin
US-2020271667-A1 · Aug 27, 2020 · US
Pct and pro-adm as markers for monitoring antibiotic treatment
US-2020264199-A1 · Aug 20, 2020 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Brahms Gmbh | 22 |
| Instituto De Investig Biomedica De Salamanca | 1 |
| Linkoping Univ Hospital | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| G01N33/74 | 21 |
| G01N2800/52 | 18 |
| G01N2800/26 | 13 |
| G01N2333/575 | 8 |
| G01N33/6893 | 7 |